Decline in serum soluble E-cadherin and low baseline matrix metalloproteinase-9 are associated with response to combination celecoxib and erlotinib therapy in advanced non-small cell lung cancer
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: K. L. Reckamp, B. K. Gardner, R. A. Figlin, D. Elashoff, K. Krysan, M. Dohadwala, L. Inge, A. Rajasekaran, S. M. Dubinett
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2254674885
